Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCAP-XX Regulatory News (CPX)

Share Price Information for CAP-XX (CPX)

Share Price is delayed by 15 minutes
Get Live Data
0.265    -0.005 (-1.85%)
Bid:
0.25
Ask:
0.28
Spread: 0.03 (12.00%)
Market Cap: £15.36m
CPX Live PriceLast checked at - London Stock Exchange

Intraday CAP-XX Share Chart

Trading update

20 Jun 2018 07:00

RNS Number : 9258R
CAP-XX Limited
20 June 2018
 

Dissemination of a Regulatory Announcement that contains inside information according to REGULATION (EU) No 596/2014 (MAR).

 

20 June 2018

 

CAP-XX Limited

("CAP-XX" or "the Company")

Trading update

 

The Board of CAP-XX is pleased to announce that as it approaches the end of its financial year ending 30 June 2018, the Company has received a sharp increase in enquiry levels across all product ranges, including its recently announced 3 Volt technology. Total enquiries, if converted to orders, would amount to annualised sales in excess of US$20m per annum, including over US$2m which has already been classed as design wins, covering over 70 projects for cylindrical and automotive supercapacitors; small IoT and Thinline supercapacitors; and the new 3 Volt prismatic supercapacitors that are in development.

Following on from the announcement made in April 2018, the Company's new 3 Volt technology programme remains on track. As previously stated, the Board believes that the development of a 3 Volt prismatic supercapacitor will be a breakthrough for IoT applications using coin cell batteries. CAP-XX is currently commencing production trials and holding discussions with potential customers and licencees.

Royalty payments continue to grow strongly. Licensing activity remains a key focus, as CAP-XX negotiates new agreements and tackles intellectual property infringements. The Company expects to announce further progress in these respects shortly.

Revenues for the second half of the financial year ending 30 June 2018 are expected to be A$3.35m, including licence payments from AVX, which are significantly ahead of the first half of the year (first half total revenues: A$1.54m). These revenues are expected to result in a reduced EBITDA loss for the second half of the year of approximately A$120,000, compared to the first half EBITDA loss of A$1.5m.

The second half of the financial year includes revenues from the previously announced high volume order for prismatic cells, which has reduced the Company's average selling price by approximately 20%. This selling price reduction, together with the extra start-up costs for this production (as already reported); relocating manufacturing assets from a former contract manufacturer's site; and pursuing patent infringement actions, has reduced the Company's margins. For the financial year ending 30 June 2018, the Board therefore anticipates CAP-XX will generate total revenues of not less than A$4.9m and an EBITDA loss of A$1.6m. Closing cash is anticipated to be in excess of A$1.8m.

 

For further information contact:

 

CAP-XX Limited

Anthony Kongats (Chief Executive Officer) +61 (0) 2 9428 0139

Kreab (Financial PR)

Robert Speed +44 (0) 20 7074 1800

Allenby Capital (Nominated Adviser and Broker)

David Hart / Alex Brearley (Corporate Finance) +44 (0) 20 3328 5656

 

More information is available at www.cap-xx.com

 

Notes to Editors:

CAP-XX (LSE: CPX) is a world leader in the design and manufacture of thin, flat supercapacitors and energy management systems used in portable and small-scale electronic devices, and large supercapacitor based modules used in larger applications such as automotive and renewable energy. The unique feature of CAP-XX supercapacitors is their very high power density and high energy storage capacity in a space-efficient prismatic package. These attributes are essential in power-hungry consumer and industrial electronics, and deliver similar benefits in automotive and other transportation applications. For more information about CAP-XX, visit www.cap-xx.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTGGUBPQUPRPPB
Date   Source Headline
23rd Apr 202110:21 amRNSAppointment of Joint Broker
30th Mar 20217:00 amRNSNotification of transactions by PDMRs
23rd Mar 20217:00 amRNSHolding(s) in Company
16th Mar 20214:40 pmRNSSecond Price Monitoring Extn
16th Mar 20214:36 pmRNSPrice Monitoring Extension
15th Mar 20217:00 amRNSPortal Instruments Selects CAP-XX Supercapacitors
25th Feb 20217:00 amRNSInterim Results
16th Feb 202112:55 pmRNSLight energy harvesting evaluation modules
9th Feb 20217:00 amRNSTrading update and notification of date of results
5th Jan 20219:06 amRNSHolding(s) in Company
4th Jan 20217:15 amRNSUpdate re Tax Rebate
31st Dec 202011:31 amRNSHolding(s) in Company
22nd Dec 202011:05 amRNSSecond Price Monitoring Extn
22nd Dec 202011:00 amRNSPrice Monitoring Extension
22nd Dec 20207:00 amRNSProduct shipped from new production lines
18th Dec 20207:00 amRNSHolding(s) in Company
10th Dec 20208:02 amRNSExercise of employee share options
30th Nov 20207:00 amRNSHolding(s) in Company
25th Nov 20208:15 amRNSResult of AGM and Chairman’s AGM statement
3rd Nov 202012:49 pmRNSReplacement: Audited results
3rd Nov 20207:00 amRNSAudited results for the year ended 30 June 2020
23rd Oct 20207:00 amRNSNotice of Results
8th Oct 20207:00 amRNSAward of LSE Green Economy Mark
10th Sep 20207:11 amRNSCorporate update
26th Aug 20208:23 amRNSHolding(s) in Company
25th Aug 202010:21 amRNSIssue of Shares
21st Aug 20204:41 pmRNSSecond Price Monitoring Extn
21st Aug 20204:36 pmRNSPrice Monitoring Extension
21st Aug 202011:05 amRNSSecond Price Monitoring Extn
21st Aug 202011:00 amRNSPrice Monitoring Extension
17th Aug 20207:35 amRNSHolding(s) in Company
7th Aug 20203:18 pmRNSIoxus intellectual property judgement
26th Jun 20207:28 amRNSIssue of Shares and Director/PDMR Shareholdings
24th Jun 20208:57 amRNSChange of Auditor
19th May 20207:00 amRNSTrading Update
29th Apr 20202:06 pmRNSSecond Price Monitoring Extn
29th Apr 20202:01 pmRNSPrice Monitoring Extension
16th Mar 20207:00 amRNSInterim Results
4th Mar 20207:00 amRNSNotification of date of interim results and update
7th Jan 20207:00 amRNSHolding(s) in Company
6th Jan 20208:22 amRNSHolding(s) in Company
30th Dec 20198:30 amRNSResult of General Meeting
24th Dec 20197:00 amRNSResult of Offer to Qualifying Participants
29th Nov 20199:57 amRNSReplacement: Proposed Acquisition and Fundraising
29th Nov 20197:00 amRNSProposed Acquisition from Murata and Fundraising
28th Nov 20198:53 amRNSResult of AGM
13th Nov 20197:00 amRNSNotice of AGM
8th Nov 20197:00 amRNSAudited results for the year ended 30 June 2019
11th Sep 20197:00 amRNSHolding(s) in Company
31st Jul 20198:48 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.